This Drug Could Be the Next Ozempic. Bootlegs Are Already Selling Online.

A Wall Street Journal review has found that a potential weight-loss drug called retatrutide, developed by Eli Lilly, is already being sold online, despite still being years away from regulatory approval in the US. The drug is being offered by hundreds of merchants, many of whom are Chinese sellers shipping directly to US consumers. Some websites, including those based in the US, have marketed the drug through social media platforms and paid advertisements. The FDA has issued warning letters to websites selling knockoff versions of other weight-loss drugs, but the sale of retatrutide highlights the thriving gray market for unapproved weight-loss medications. [Extracted from the article]